Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacy-based Non-interventional Study (NIS) With Iberogast® Advance (STW 5 II).

NCT05389709 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05389709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacy-based Non-interventional Study (NIS) With Iberogast® Advance (STW 5 II).
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
June 4, 2022
Completion date
May 11, 2023
Enrollment
184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional dyspepsia, functional gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia, irritable bowel syndrome